71 Best CyberKnife Doctors Abroad

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Ertugrul Pinar is a neurosurgeon at Hisar Hospital Intercontinental in Istanbul. He treats adult and pediatric patients with complex brain and spine diseases. Dr. Pinar focuses on brain tumors, vascular aneurysms, and skull base pathologies. He works at a JCI-accredited hospital that serves over 500,000 patients annually.

• Performs specialized procedures including transnasal tumor resection and brain aneurysm repair.
• Treats a wide range of conditions like pituitary adenomas and arteriovenous malformations.
• Expertise covers both surgical oncology and reconstructive spine surgery for herniated disks.
• Provides care for pediatric neurosurgical cases including hydrocephalus and shunt surgeries.

Banu Atalar trained at Stanford University in stereotactic radiosurgery – bringing cutting-edge CyberKnife expertise to Anadolu Medical Center.

• Professor of Radiation Oncology with 18+ years of experience
• Fellowship-trained in MR-guided adaptive SRS techniques
• 75% of practice focused on stereotactic treatments
• Honorary Fellow of American College of Radiology
• President of Turkish Society for Radiation Oncology

Dr. Ahmet Hilmi Kaya is a professor of neurosurgery at Anadolu Medical Center in Istanbul. He specializes in functional neurosurgery and deep brain stimulation (DBS) for movement disorders. Dr. Kaya previously led a Parkinson’s disease research project at Ondokuz Mayıs University. He earned the Aysima Altınok Thesis Award from the Turkish Neurosurgical Society.

• Performs complex brain tumor removals and skull base surgeries.
• Treats spinal conditions including tumors, stenosis, and herniated discs.
• Completed specialized observerships in cellular neuroscience at Maastricht University.
• Works at Anadolu Medical Center, an affiliate of Johns Hopkins Medicine.

Head of Functional Neurosurgery and Radiosurgery at Ruber International Hospital since 2005 – specializing in CyberKnife treatments.

• 42 years of experience in neurosurgery and radiosurgery
• Published 180 articles and 3 books on neurosurgical topics
• Member of the Executive Council of the International Society of Stereotactic Radiosurgery
• Trained at prestigious hospitals in France, Sweden, and the UK
• Honorary Professor at the Autonomous University of Madrid

Dr. Ari Raphael leads the Israeli National Genomic Medicine Initiative at TASMC and specializes in precision oncology for lung and breast cancer.

• Senior Lecturer at Tel Aviv University's Faculty of Medicine
• Principal Investigator for multiple clinical trials using genomic profiling
• Molecular Tumor Board moderator for the Israeli Lung Cancer Society
• Fellowship-trained in innovation and biomedical informatics
• Recipient of the ISCORT research grant for oncology studies

Dr. Mehmet Tonge specializes in Stereotactic & Functional Neurosurgery, with extensive research and clinical focus on Gamma Knife Radiosurgery.

• 32 publications and 12 book chapters on Stereotactic Neurosurgery
• Member of World Stereotactic & Functional Neurosurgery Society
• Assistant Professor at Istanbul Medipol University
• Trained at Zurich University Hospital in microneurosurgery

Prof. Dr. Hasan Ozgur Ozdemir specializes in advanced neurosurgery techniques, including CyberKnife treatments, at Medical Park Antalya Hospital Complex.

• Over 24 years of experience in neurosurgery
• Expert in endoscopic and minimally invasive brain and spine surgeries
• First place in Turkish Neurosurgical Society Proficiency Exam
• Member of Turkish Neurosurgical Society and Turkish Medical Association

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Zvi Cohen is the Director of the Neurosurgery Department at Sheba Medical Center. He was recently recognized in Forbes Israel’s Best Doctors list for 2025. Dr. Cohen specializes in treating complex brain, pituitary, and spinal cord tumors. He founded the brain tumor tissue bank at Sheba to support oncological research. Dr. Cohen is board-certified in neurosurgery and leads clinical trials for malignant brain tumors.

• Completed fellowships in neurosurgical oncology at MD Anderson and neuroradiology at Beth Israel.
• Expert in intraoperative MRI, stereotactic biopsies, and image-guided resections.
• Performs radiosurgery and minimally invasive microsurgery for CNS tumors.
• Member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Specializes in CyberKnife treatments with expertise in stereotactic and functional neurosurgery – trained at Hannover Medical School.

• Associate Professor at Florence Nightingale Hospitals
• Fellowship-trained in Germany for advanced neurosurgical techniques
• 20 years of neurosurgery experience
• Works at one of Turkey's top medical facilities

Prof. Amit Tirosh leads Sheba Medical Center's Neuroendocrine Tumors Service, specializing in hereditary endocrine conditions.

• Heads Endocrine Oncology Bioinformatics Lab with international collaborations
• Expert in Peptide Receptor Radionuclide Therapy (PRRT) for NETs
• Trained at National Institutes of Health in endocrine tumor genetics
• Published 40+ papers on NET management in top medical journals

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Zuleyha Akgun is a radiation oncology specialist at Memorial Şişli Hospital in Istanbul. She focalizes on cancer treatment using targeted radiation therapy. Dr. Akgun has practiced at some of Turkey’s most active medical institutions since 2003. She serves patients at a JCI-accredited facility recognized for its high medical safety standards.

• Practices at Memorial Şişli Hospital, the first Turkish hospital to earn JCI accreditation.
• Completed a research residency at Marmara University Faculty of Medicine.
• Treats patients in a specialized oncology center that attracts international cases from 160+ countries.
• Previously served as a specialist at Erzurum Regional Training and Research Hospital.

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.